Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
European Journal of Medical Research
Published in: European Journal of Medical Research 1/2014

Open Access 01-12-2014 | Case report

Recurrent lymphocytic myocarditis in a young male with ulcerative colitis

Authors: Varnavas C Varnavas, Nico Reinsch, Mareike Perrey, Felix Nensa, Thomas Schlosser, Hideo A Baba, Guido Gerken, Raimund Erbel, Rolf A Janosi, Antonios Katsounas

Published in: European Journal of Medical Research | Issue 1/2014

Login to get access

Abstract

Awareness of myocarditis in association with inflammatory bowel diseases is crucial as it bears a rare but serious risk for mortality. This report describes the case of a young Caucasian male, whose heart biopsy was tested negative for giant cells and bacterial or viral genomes or proteins. He was experiencing severe lymphocytic myocarditis (other than mesalamine-induced) along with cardiogenic shock during ulcerative colitis exacerbation. This is an extremely rare, if not unique, clinical constellation. We chose to study the epidemiologic grounds and all major aspects of differential pathogenesis and treatment of this serious health problem.
Appendix
Available only for authorised users
Literature
1.
Mowat NA, Bennett PN, Finlayson JK, Brunt PW, Lancaster WM: Myopericarditis complicating ulcerative colitis. Br Heart J 1974, 36: 724–727. 10.1136/hrt.36.7.724PubMedPubMedCentralCrossRef
2.
Sorensen HT, Fonager KM: Myocarditis and inflammatory bowel disease. A 16-year Danish nationwide cohort study. Dan Med Bull 1997, 44: 442–444.PubMed
3.
4.
Davidoff R, Palacios I, Southern J, Fallon JT, Newell J, Dec GW: Giant cell versus lymphocytic myocarditis. A comparison of their clinical features and long-term outcomes. Circulation 1991, 83: 953–961. 10.1161/01.CIR.83.3.953PubMedCrossRef
5.
Cooper LT Jr, Berry GJ, Shabetai R: Idiopathic giant-cell myocarditis – natural history and treatment. N Engl J Med 1860–1866, 1997: 336.
6.
Davies MJ, Pomerance A, Teare RD: Idiopathic giant cell myocarditis – a distinctive clinico-pathological entity. Br Heart J 1975, 37: 192–195. 10.1136/hrt.37.2.192PubMedPubMedCentralCrossRef
7.
Frustaci A, Chimenti C, Calabrese F, Pieroni M, Thiene G, Maseri A: Immunosuppressive therapy for active lymphocytic myocarditis: virological and immunologic profile of responders versus nonresponders. Circulation 2003, 107: 857–863. 10.1161/01.CIR.0000048147.15962.31PubMedCrossRef
8.
Mason JW, O’Connell JB, Herskowitz A, Rose NR, McManus BM, Billingham ME, Moon TE: A clinical trial of immunosuppressive therapy for myocarditis. N Engl J Med 1995, 333: 269–275. 10.1056/NEJM199508033330501PubMedCrossRef
9.
Wojnicz R, Nowalany-Kozielska E, Wojciechowska C, Glanowska G, Wilczewski P, Niklewski T, Zembala M, Polonski L, Rozek MM, Wodniecki J: Randomized, placebo-controlled study for immunosuppressive treatment of inflammatory dilated cardiomyopathy: two-year follow-up results. Circulation 2001, 104: 39–45. 10.1161/01.CIR.104.1.39PubMedCrossRef
10.
Maisch B, Seferovic PM, Ristic AD, Erbel R, Rienmuller R, Adler Y, Tomkowski WZ, Thiene G, Yacoub MH: Guidelines on the diagnosis and management of pericardial diseases executive summary. Eur Heart J 2004, 25: 587–610.PubMedCrossRef
11.
Stelts S, Taylor MH, Nappi J, Van Bakel AB: Mesalamine-associated hypersensitivity myocarditis in ulcerative colitis. Ann Pharmacother 2008, 42: 904–905. 10.1345/aph.1K288PubMedCrossRef
12.
Naranjo CA, Busto U, Sellers EM, Sandor P, Ruiz I, Roberts EA, Janecek E, Domecq C, Greenblatt DJ: A method for estimating the probability of adverse drug reactions. Clin Pharmacol Ther 1981, 30: 239–245. 10.1038/clpt.1981.154PubMedCrossRef
Metadata
Title
Recurrent lymphocytic myocarditis in a young male with ulcerative colitis
Authors
Varnavas C Varnavas
Nico Reinsch
Mareike Perrey
Felix Nensa
Thomas Schlosser
Hideo A Baba
Guido Gerken
Raimund Erbel
Rolf A Janosi
Antonios Katsounas
Publication date
01-12-2014
Publisher
BioMed Central
Published in
European Journal of Medical Research / Issue 1/2014
Electronic ISSN: 2047-783X
DOI
https://doi.org/10.1186/2047-783X-19-11

Other articles of this Issue 1/2014

European Journal of Medical Research 1/2014 Go to the issue

Research

IGF2BP2 and obesity interaction analysis for type 2 diabetes mellitus in Chinese Han population

Research

Diverse expression of selected cytokines and proteinases in synovial fluid obtained from osteoarthritic and healthy human knee joints

Research

Influence of testosterone replacement therapy on metabolic disorders in male patients with type 2 diabetes mellitus and androgen deficiency

Research

Multiple sclerosis: clinical features and MRI findings in Northern China

Research article

Closing-opening wedge osteotomy for thoracolumbar traumatic kyphosis

Research

Nasal position of nasotracheal tubes: a retrospective analysis of intraoperatively generated three-dimensional X-rays during maxillofacial surgery